Calcium citrate: from biochemistry and physiology to clinical applications

被引:35
作者
Palermo, Andrea [1 ]
Naciu, Anda Mihaela [1 ]
Tabacco, Gaia [1 ]
Manfrini, Silvia [1 ]
Trimboli, Pierpaolo [2 ,3 ]
Vescini, Fabio [4 ]
Falchetti, Alberto [5 ,6 ,7 ]
机构
[1] Campus Biomed Univ, Unit Endocrinol & Diabet, Rome, Italy
[2] Imaging Inst Southern Switzerland, Dept Nucl Med, Lugano, Switzerland
[3] Imaging Inst Southern Switzerland, Thyroid Ctr, Lugano, Switzerland
[4] Univ Hosp S Maria della Misericordia Udine, Endocrinol & Metab Unit, I-33100 Udine, Italy
[5] Univ Milan, Unit Bone Metab Dis & Diabet, IRCCS, Ist Auxol Italiano, Milan, Italy
[6] Univ Milan, Lab Endocrine & Metab Res, Milan, Italy
[7] Villa Donatello Private Hosp, EndOsMet, Florence, Italy
关键词
Calcium; Citrate; Osteoporosis; Bariatric surgery; Fracture; BARIATRIC SURGERY; VITAMIN-D; BONE LOSS; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; POTASSIUM CITRATE; STONE FORMERS; CARRIER GENE; SUPPLEMENTATION; ABSORPTION;
D O I
10.1007/s11154-019-09520-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adequate daily calcium intake should normally be achieved by dietary sources. Since low calcium diets are quite common in subjects that do not reach the recommended intake and particularly those at risk of fractures, calcium supplements may become necessary. Different forms of calcium salts are available, but products containing calcium citrate and calcium carbonate complexes are the most frequently used. Although only limited evidence on the efficacy and long-term safety of calcium citrate is available, these supplements may represent a valuable product for the management of different chronic pathological conditions. The aim of this review was to evaluate the current and potential clinical applications of calcium citrate. In particular, we focused on the use of calcium citrate supplementation in subjects with osteoporosis or in bariatric patients. Other pathological conditions that could benefit calcium citrate supplementation may include achloridria, chronic hypoparathyroidism and hypocitraturic subjects with moderate/high risk of nephrolithiasis. Indeed, citrate salts are widely used in the treatment of nephrolithiasis, since they have shown an inhibitory effect on kidney stone formation and recurrence.
引用
收藏
页码:353 / 364
页数:12
相关论文
共 77 条
[1]   Nephrolithiasis: Molecular Mechanism of Renal Stone Formation and the Critical Role Played by Modulators [J].
Aggarwal, Kanu Priya ;
Narula, Shifa ;
Kakkar, Monica ;
Tandon, Chanderdeep .
BIOMED RESEARCH INTERNATIONAL, 2013, 2013
[2]   Hyperoxaluria in kidney stone formers treated with modern bariatric surgery [J].
Asplin, John R. ;
Coe, Fredric L. .
JOURNAL OF UROLOGY, 2007, 177 (02) :565-569
[3]   RANDOMIZED DOUBLE-BLIND-STUDY OF POTASSIUM CITRATE IN IDIOPATHIC HYPOCITRATURIC CALCIUM NEPHROLITHIASIS [J].
BARCELO, P ;
WUHL, O ;
SERVITGE, E ;
ROUSAUD, A ;
PAK, CYC .
JOURNAL OF UROLOGY, 1993, 150 (06) :1761-1764
[4]   SECONDARY HYPERPARATHYROIDISM AFTER BARIATRIC SURGERY: TREATMENT IS WITH CALCIUM CARBONATE OR CALCIUM CITRATE? [J].
Baretta, Giorgio Alfredo Pedroso ;
Cambi, Maria Paula Carlini ;
Rodrigues, Arieli Luz ;
Mendes, Silvana Aparecida .
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2015, 28 :43-45
[5]   Mechanisms of intestinal calcium absorption [J].
Bronner, F .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) :387-393
[6]   Diet-Induced Low-Grade Metabolic Acidosis and Clinical Outcomes: A Review [J].
Carnauba, Renata Alves ;
Baptistella, Ana Beatriz ;
Paschoal, Valeria ;
Hubscher, Gilberti Helena .
NUTRIENTS, 2017, 9 (06)
[7]  
Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220
[8]  
CAUDARELLA R, 1995, ITAL J MINER ELECT M, V9, P31
[9]  
Caudarella R, 2000, ITAL J MINER ELECT M, V14
[10]  
Caudarella Renata, 2003, Frontiers in Bioscience, V8, P1084